Profitable Insulin Injectable Business
Diabetes is one of the promising therapeutic segments in UK injectable market. In 1996 approximately 1.6 Million people were diagnosed with diabetes, it has reached 3 Million now. The disease has become widespread across the country with a current prevalence rate of approximately 4.6%. Such remarkable increasing prevalence of diabetics in UK has prompted pharmaceutical players to innovate technologically advanced products. Apart from this, several small pharmaceutical companies has started offering diabetes injectables. Due to this the demand for insulin...
View full press release